Pharmacokinetics of new antiherpetic agents

Clinical Pharmacokinetics
P Rolan

Abstract

Valaciclovir and famciclovir, two new prodrugs (for aciclovir and penciclovir, respectively) have similar pharmacokinetics in many regards. Both have good but incomplete bioavailability, with the conversion to the active forms taking place in the liver, but by different cytosolic enzymes. Absorption and conversion are consistent in relevant patient groups, including those with liver disease. The pharmacokinetics of both active molecules are also similar in being mainly renally eliminated, a significant component of which is tubular secretion, and elimination half-lives from plasma of approximately 2.2 to 2.5 hours. Dosage adjustment is required in the presence of renal impairment. No clinically important drug interactions have been identified with either drug. The choice between the two agents is likely to depend on clinical factors such as tolerability, safety, efficacy, compliance and possibly cost, rather than on their pharmacokinetics.

Citations

Apr 1, 1996·Molecular Biotechnology·S Freeman, J M Gardiner
May 15, 2002·Archives of Pharmacal Research·Henry J LeeDong-Hoon Ko
Mar 30, 2013·The Journal of Antimicrobial Chemotherapy·Fanny SchenkelYoussef Daali
Aug 24, 1999·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D JayasekaraJ G Gambertoglio
Feb 6, 2004·Clinical and Experimental Pharmacology & Physiology·Jiping WangSusan Cox
Feb 1, 1997·Expert Opinion on Investigational Drugs·R Patel
Oct 22, 2009·British Journal of Clinical Pharmacology·Kayode OgungbenroLeon Aarons
Dec 17, 2014·International Journal of STD & AIDS·Melissa Pinder, Alison Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.